These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 11805192)
1. The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms. McCarver DG; Hines RN J Pharmacol Exp Ther; 2002 Feb; 300(2):361-6. PubMed ID: 11805192 [TBL] [Abstract][Full Text] [Related]
2. Effects of aging and caloric restriction on hepatic drug metabolizing enzymes in the Fischer 344 rat. II: Effects on conjugating enzymes. Leakey JA; Cunny HC; Bazare J; Webb PJ; Lipscomb JC; Slikker W; Feuers RJ; Duffy PH; Hart RW Mech Ageing Dev; 1989 May; 48(2):157-66. PubMed ID: 2500570 [TBL] [Abstract][Full Text] [Related]
3. Main drug- and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissues. Toussaint C; Albin N; Massaad L; Grunenwald D; Parise O; Morizet J; Gouyette A; Chabot GG Cancer Res; 1993 Oct; 53(19):4608-12. PubMed ID: 8402635 [TBL] [Abstract][Full Text] [Related]
4. Tissue distribution of drug-metabolizing enzymes in humans. Pacifici GM; Franchi M; Bencini C; Repetti F; Di Lascio N; Muraro GB Xenobiotica; 1988 Jul; 18(7):849-56. PubMed ID: 3140501 [TBL] [Abstract][Full Text] [Related]
5. The ontogeny of human drug-metabolizing enzymes: phase I oxidative enzymes. Hines RN; McCarver DG J Pharmacol Exp Ther; 2002 Feb; 300(2):355-60. PubMed ID: 11805191 [TBL] [Abstract][Full Text] [Related]
6. Main drug-metabolizing enzyme systems in human breast tumors and peritumoral tissues. Albin N; Massaad L; Toussaint C; Mathieu MC; Morizet J; Parise O; Gouyette A; Chabot GG Cancer Res; 1993 Aug; 53(15):3541-6. PubMed ID: 8339260 [TBL] [Abstract][Full Text] [Related]
7. Ontogeny of Human Conjugating Enzymes. Coughtrie MW Drug Metab Lett; 2015; 9(2):99-108. PubMed ID: 26031463 [TBL] [Abstract][Full Text] [Related]
8. The influence of inducers on drug-metabolizing enzyme activity and on formation of reactive drug metabolites in the liver. Orrenius S; Thor H; Jernström B Ciba Found Symp; 1980; 76():25-42. PubMed ID: 6109599 [TBL] [Abstract][Full Text] [Related]
9. Hepatic drug-metabolizing enzymes in primary and secondary tumors of human liver. el Mouelhi M; Didolkar MS; Elias EG; Guengerich FP; Kauffman FC Cancer Res; 1987 Jan; 47(2):460-6. PubMed ID: 3024821 [TBL] [Abstract][Full Text] [Related]
10. Multiplicity of liver drug metabolizing enzymes. Lu AY Drug Metab Rev; 1979; 10(2):187-208. PubMed ID: 121803 [No Abstract] [Full Text] [Related]
11. A comparison of the expression and metabolizing activities of phase I and II enzymes in freshly isolated human lung parenchymal cells and cryopreserved human hepatocytes. Somers GI; Lindsay N; Lowdon BM; Jones AE; Freathy C; Ho S; Woodrooffe AJ; Bayliss MK; Manchee GR Drug Metab Dispos; 2007 Oct; 35(10):1797-805. PubMed ID: 17627976 [TBL] [Abstract][Full Text] [Related]
12. Comparative gene expression of intestinal metabolizing enzymes. Shin HC; Kim HR; Cho HJ; Yi H; Cho SM; Lee DG; Abd El-Aty AM; Kim JS; Sun D; Amidon GL Biopharm Drug Dispos; 2009 Nov; 30(8):411-21. PubMed ID: 19746353 [TBL] [Abstract][Full Text] [Related]
13. Modulation of phase II enzymes by organosulfur compounds from allium vegetables in rat tissues. Guyonnet D; Siess MH; Le Bon AM; Suschetet M Toxicol Appl Pharmacol; 1999 Jan; 154(1):50-8. PubMed ID: 9882591 [TBL] [Abstract][Full Text] [Related]
14. [Role of monoxygenases in the metabolism of drugs in the human fetus and newborn infant]. Cresteil T; Leroux JP Arch Fr Pediatr; 1982; 39(7):463-70. PubMed ID: 6816186 [TBL] [Abstract][Full Text] [Related]
15. Postnatal development of renal and hepatic drug-metabolizing enzymes in male and female Fischer 344 rats. Kuo CH; Hook JB Life Sci; 1980 Dec 22-29; 27(25-26):2433-8. PubMed ID: 6783794 [No Abstract] [Full Text] [Related]
16. Phase I and phase II drug-metabolizing enzymes are expressed and heterogeneously distributed in the biliary epithelium. Lakehal F; Wendum D; Barbu V; Becquemont L; Poupon R; Balladur P; Hannoun L; Ballet F; Beaune PH; Housset C Hepatology; 1999 Dec; 30(6):1498-506. PubMed ID: 10573530 [TBL] [Abstract][Full Text] [Related]
17. Principal xenobiotic-metabolizing enzyme systems in human head and neck squamous cell carcinoma. Janot F; Massaad L; Ribrag V; de Waziers I; Beaune PH; Luboinski B; Parise O; Gouyette A; Chabot GG Carcinogenesis; 1993 Jul; 14(7):1279-83. PubMed ID: 8330340 [TBL] [Abstract][Full Text] [Related]
19. Phase II enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells. Westerink WM; Schoonen WG Toxicol In Vitro; 2007 Dec; 21(8):1592-602. PubMed ID: 17716855 [TBL] [Abstract][Full Text] [Related]
20. Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs. Urquhart BL; Tirona RG; Kim RB J Clin Pharmacol; 2007 May; 47(5):566-78. PubMed ID: 17442683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]